首页 > 最新文献

Clinical and Molecular Hepatology最新文献

英文 中文
Unveiling etiology-specific blood biomarkers in hepatocellular carcinoma: A gateway to personalized medicine: Editorial on "Multiomics profiling of buffy coat and plasma unveils etiology-specific signatures in hepatocellular carcinoma". 揭示肝细胞癌病因特异性血液生物标志物:通向个性化医疗的大门
IF 14 1区 医学 Q1 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2024-10-01 Epub Date: 2024-05-14 DOI: 10.3350/cmh.2024.0348
Joseph C Ahn, Ju Dong Yang
{"title":"Unveiling etiology-specific blood biomarkers in hepatocellular carcinoma: A gateway to personalized medicine: Editorial on \"Multiomics profiling of buffy coat and plasma unveils etiology-specific signatures in hepatocellular carcinoma\".","authors":"Joseph C Ahn, Ju Dong Yang","doi":"10.3350/cmh.2024.0348","DOIUrl":"10.3350/cmh.2024.0348","url":null,"abstract":"","PeriodicalId":10275,"journal":{"name":"Clinical and Molecular Hepatology","volume":null,"pages":null},"PeriodicalIF":14.0,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11540397/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140916247","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Genetically-modified, redirected T cells target hepatitis B surface antigen-positive hepatocytes and hepatocellular carcinoma lesions in a clinical setting. 基因重定向的 HBV 特异性 T 细胞靶向 HBsAg 阳性肝细胞和 HBV 相关性 HCC 的原发病灶。
IF 14 1区 医学 Q1 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2024-10-01 Epub Date: 2024-05-29 DOI: 10.3350/cmh.2024.0058
Xueshuai Wan, Karin Wisskirchen, Tao Jin, Lu Yang, Xiaorui Wang, Xiang'an Wu, Fang Liu, Yu Wu, Christy Ma, Yong Pang, Qi Li, Ke Zhang, Ulrike Protzer, Shunda Du

Background/aims: Hepatitis B virus (HBV)-DNA integration in HBV-related hepatocellular carcinoma (HBV-HCC) can be targeted by HBV-specific T cells. SCG101 is an autologous, HBV-specific T-cell product expressing a T-cell receptor (TCR) after lentiviral transduction recognizing the envelope-derived peptide (S20-28) on HLA-A2. We here validated its safety and efficacy preclinically and applied it to an HBV-related HCC patient (NCT05339321).

Methods: Good Manufacturing Practice-grade manufactured cells were assessed for off-target reactivity and functionality against hepatoma cells. Subsequently, a patient with advanced HBV-HCC (Child-Pugh class A, Barcelona Clinic Liver Cancer stage B, Eastern Cooperative Oncology Group performance status 0, hepatitis B e antigen-, serum hepatitis B surface antigen [HBsAg]+, HBsAg+ hepatocytes 10%) received 7.9×107 cells/kg after lymphodepletion. Safety, T-cell persistence, and antiviral and antitumor efficacy were evaluated.

Results: SCG101, produced at high numbers in a closed-bag system, showed HBV-specific functionality against HBV-HCC cells in vitro and in vivo. Clinically, treatment was well tolerated, and all adverse events, including transient hepatic damage, were reversible. On day 3, ALT levels increased to 1,404 U/L, and concurrently, serum HBsAg started decreasing by 3.84 log10 and remained <1 IU/mL for over six months. HBsAg-expressing hepatocytes in liver biopsies were undetectable after 73 days. The patient achieved a partial response according to modified RECIST with a >70% reduction in target lesion size. Transferred T cells expanded, developed a stem cell-like memory phenotype, and were still detectable after six months in the patient's blood.

Conclusion: SCG101 T-cell therapy showed encouraging efficacy and safety in preclinical models and in a patient with primary HBV-HCC and concomitant chronic hepatitis B with the capability to eliminate HBsAg+ cells and achieve sustained tumor control after single dosing.

背景和目的:HBV相关肝细胞癌(HBV-HCC)中的HBV-DNA整合可被HBV特异性T细胞靶向。SCG101 是一种自体 HBV 特异性 T 细胞产品,经慢病毒转导后可表达 T 细胞受体 (TCR),识别 HLA-A2 上的包膜衍生肽 (S20-28)。我们在此对其安全性和有效性进行了临床前验证,并将其应用于一名与 HBV 相关的 HCC 患者(NCT05339321):方法:评估了 GMP 级制备细胞的脱靶反应性和对肝癌细胞的功能性。随后,一名晚期 HBV-HCC 患者(Child-Pugh:A、BCLC:B、ECOG:0、HBeAg-、血清 HBsAg+、肝细胞 10% HBsAg+)在淋巴清扫后接受了 7.9x107 cells/kg。对安全性、T细胞持久性、抗病毒和抗肿瘤疗效进行了评估:结果:在封闭袋系统中大量生产的SCG101在体外和体内对HBV-肝癌细胞具有HBV特异性功能。在临床上,治疗的耐受性良好,所有不良反应,包括短暂的肝损伤,都是可逆的。治疗第3天,ALT水平升至1404 U/ml,与此同时,血清HBsAg开始下降3.84log,目标病灶缩小了70%。转移的T细胞扩增,形成了干细胞样记忆表型,6个月后仍能在患者血液中检测到:结论:SCG101 T细胞疗法在临床前模型和原发性HBV-HCC合并慢性乙型肝炎患者中显示出令人鼓舞的疗效和安全性,能够清除HBsAg+细胞,并在单次给药后实现持续的肿瘤控制。
{"title":"Genetically-modified, redirected T cells target hepatitis B surface antigen-positive hepatocytes and hepatocellular carcinoma lesions in a clinical setting.","authors":"Xueshuai Wan, Karin Wisskirchen, Tao Jin, Lu Yang, Xiaorui Wang, Xiang'an Wu, Fang Liu, Yu Wu, Christy Ma, Yong Pang, Qi Li, Ke Zhang, Ulrike Protzer, Shunda Du","doi":"10.3350/cmh.2024.0058","DOIUrl":"10.3350/cmh.2024.0058","url":null,"abstract":"<p><strong>Background/aims: </strong>Hepatitis B virus (HBV)-DNA integration in HBV-related hepatocellular carcinoma (HBV-HCC) can be targeted by HBV-specific T cells. SCG101 is an autologous, HBV-specific T-cell product expressing a T-cell receptor (TCR) after lentiviral transduction recognizing the envelope-derived peptide (S20-28) on HLA-A2. We here validated its safety and efficacy preclinically and applied it to an HBV-related HCC patient (NCT05339321).</p><p><strong>Methods: </strong>Good Manufacturing Practice-grade manufactured cells were assessed for off-target reactivity and functionality against hepatoma cells. Subsequently, a patient with advanced HBV-HCC (Child-Pugh class A, Barcelona Clinic Liver Cancer stage B, Eastern Cooperative Oncology Group performance status 0, hepatitis B e antigen-, serum hepatitis B surface antigen [HBsAg]+, HBsAg+ hepatocytes 10%) received 7.9×107 cells/kg after lymphodepletion. Safety, T-cell persistence, and antiviral and antitumor efficacy were evaluated.</p><p><strong>Results: </strong>SCG101, produced at high numbers in a closed-bag system, showed HBV-specific functionality against HBV-HCC cells in vitro and in vivo. Clinically, treatment was well tolerated, and all adverse events, including transient hepatic damage, were reversible. On day 3, ALT levels increased to 1,404 U/L, and concurrently, serum HBsAg started decreasing by 3.84 log10 and remained <1 IU/mL for over six months. HBsAg-expressing hepatocytes in liver biopsies were undetectable after 73 days. The patient achieved a partial response according to modified RECIST with a >70% reduction in target lesion size. Transferred T cells expanded, developed a stem cell-like memory phenotype, and were still detectable after six months in the patient's blood.</p><p><strong>Conclusion: </strong>SCG101 T-cell therapy showed encouraging efficacy and safety in preclinical models and in a patient with primary HBV-HCC and concomitant chronic hepatitis B with the capability to eliminate HBsAg+ cells and achieve sustained tumor control after single dosing.</p>","PeriodicalId":10275,"journal":{"name":"Clinical and Molecular Hepatology","volume":null,"pages":null},"PeriodicalIF":14.0,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11540345/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141160950","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Severity of microvascular invasion does matter in hepatocellular carcinoma prognosis: Editorial on "Classification of microvascular invasion of hepatocellular carcinoma: correlation with prognosis and magnetic resonance imaging". 微血管侵犯的严重程度对肝癌预后有影响。
IF 14 1区 医学 Q1 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2024-10-01 Epub Date: 2024-07-01 DOI: 10.3350/cmh.2024.0482
Abdelrahman M Attia, Hasmik Adetyan, Ju Dong Yang
{"title":"Severity of microvascular invasion does matter in hepatocellular carcinoma prognosis: Editorial on \"Classification of microvascular invasion of hepatocellular carcinoma: correlation with prognosis and magnetic resonance imaging\".","authors":"Abdelrahman M Attia, Hasmik Adetyan, Ju Dong Yang","doi":"10.3350/cmh.2024.0482","DOIUrl":"10.3350/cmh.2024.0482","url":null,"abstract":"","PeriodicalId":10275,"journal":{"name":"Clinical and Molecular Hepatology","volume":null,"pages":null},"PeriodicalIF":14.0,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11540395/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141466590","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Class II transactivator restricts viral replication, extending its effect to HBV: Editorial on "Novel role of MHC class II transactivator in hepatitis B virus replication and viral counteraction". 二类反式激活因子限制病毒复制,扩大对 HBV 的影响。
IF 14 1区 医学 Q1 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2024-10-01 Epub Date: 2024-07-03 DOI: 10.3350/cmh.2024.0465
Cho-Rong Lee, Sung-Gyoo Park
{"title":"Class II transactivator restricts viral replication, extending its effect to HBV: Editorial on \"Novel role of MHC class II transactivator in hepatitis B virus replication and viral counteraction\".","authors":"Cho-Rong Lee, Sung-Gyoo Park","doi":"10.3350/cmh.2024.0465","DOIUrl":"10.3350/cmh.2024.0465","url":null,"abstract":"","PeriodicalId":10275,"journal":{"name":"Clinical and Molecular Hepatology","volume":null,"pages":null},"PeriodicalIF":14.0,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11540375/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141491125","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Decreasing performance of HCC prediction models during antiviral therapy for hepatitis B: what else to keep in mind: Editorial on "Hepatocellular carcinoma prediction model performance decreases with long-term antiviral therapy in chronic hepatitis B patients". 乙型肝炎抗病毒治疗期间 HCC 预测模型性能下降:还需注意什么?
IF 14 1区 医学 Q1 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2024-10-01 Epub Date: 2024-07-08 DOI: 10.3350/cmh.2024.0499
Beom Kyung Kim
{"title":"Decreasing performance of HCC prediction models during antiviral therapy for hepatitis B: what else to keep in mind: Editorial on \"Hepatocellular carcinoma prediction model performance decreases with long-term antiviral therapy in chronic hepatitis B patients\".","authors":"Beom Kyung Kim","doi":"10.3350/cmh.2024.0499","DOIUrl":"10.3350/cmh.2024.0499","url":null,"abstract":"","PeriodicalId":10275,"journal":{"name":"Clinical and Molecular Hepatology","volume":null,"pages":null},"PeriodicalIF":14.0,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11540388/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141554247","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Non-linear association between liver fibrosis scores and viral load in patients with chronic hepatitis B. 慢性乙型肝炎患者肝纤维化评分与病毒载量之间的非线性关系
IF 14 1区 医学 Q1 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2024-10-01 Epub Date: 2024-07-19 DOI: 10.3350/cmh.2024.0252
Gi-Ae Kim, Seung Won Choi, Seungbong Han, Young-Suk Lim

Background/aims: Serum hepatitis B virus (HBV) DNA levels and non-invasive liver fibrosis scores are significantly associated with hepatocellular carcinoma (HCC) risk in chronic hepatitis B (CHB) patients. Nonetheless, the relationship between HBV DNA levels and liver fibrosis scores is unclear.

Methods: A historical cohort comprising 6,949 non-cirrhotic Korean CHB patients without significant alanine aminotransferase elevation was investigated. The association of HBV DNA levels with the aspartate aminotransferase to platelet ratio index (APRI) and fibrosis (FIB)-4 score at baseline was analyzed using general linear models.

Results: In HBeAg-negative patients (n=4,868), HBV DNA levels correlated linearly with both APRI and FIB-4 scores. In contrast, in HBeAg-positive patients (n=2,081), HBV DNA levels correlated inversely with both APRI and FIB-4 scores. Across the entire cohort, a significant non-linear parabolic relationship was identified between HBV DNA levels and fibrosis scores, independent of age and other covariates. Notably, moderate viral loads (6-7 log10 IU/mL) corresponded to the highest APRI and FIB-4 scores (p<0.001). Over a median 10-year follow-up, 435 patients (6.3%) developed HCC. Higher APRI scores ≥0.5 and FIB-4 scores ≥1.45 were significantly associated with elevated HCC risk (p<0.001 for both). HBV DNA level remained a significant predictive factor for HCC development, even after adjusting for APRI or FIB-4 scores.

Conclusion: HBV viral load is significantly correlated with APRI and FIB-4 scores, and is also associated with HCC risk independent of those scores in CHB patients. These findings suggest that HBV DNA level is associated with hepatocarcinogenesis through both direct and indirect pathways.

背景/目的:血清乙型肝炎病毒(HBV)DNA水平和非侵入性肝纤维化评分与慢性乙型肝炎(CHB)患者的肝细胞癌(HCC)风险显著相关。然而,HBV DNA水平与肝纤维化评分之间的关系尚不清楚:方法:调查了由 6,949 名无肝硬化、丙氨酸氨基转移酶无明显升高的韩国慢性乙型肝炎患者组成的历史队列。采用一般线性模型分析了基线时 HBV DNA 水平与天冬氨酸氨基转移酶与血小板比值指数(APRI)和纤维化(FIB)-4 评分的关系:结果:在 HBeAg 阴性患者(4 868 人)中,HBV DNA 水平与 APRI 和 FIB-4 评分呈线性相关。相比之下,在 HBeAg 阳性患者(人数=2,081)中,HBV DNA 水平与 APRI 和 FIB-4 评分成反比。在整个队列中,HBV DNA 水平与纤维化评分之间存在显著的非线性抛物线关系,不受年龄和其他协变量的影响。值得注意的是,中等病毒载量(6-7 log10 IU/mL)与最高的 APRI 和 FIB-4 评分相对应(PConclusions:HBV病毒载量与APRI和FIB-4评分有明显相关性,而且与HCC风险相关,与CHB患者的这些评分无关。这些研究结果表明,HBV DNA水平通过直接和间接途径与肝癌发生相关。
{"title":"Non-linear association between liver fibrosis scores and viral load in patients with chronic hepatitis B.","authors":"Gi-Ae Kim, Seung Won Choi, Seungbong Han, Young-Suk Lim","doi":"10.3350/cmh.2024.0252","DOIUrl":"10.3350/cmh.2024.0252","url":null,"abstract":"<p><strong>Background/aims: </strong>Serum hepatitis B virus (HBV) DNA levels and non-invasive liver fibrosis scores are significantly associated with hepatocellular carcinoma (HCC) risk in chronic hepatitis B (CHB) patients. Nonetheless, the relationship between HBV DNA levels and liver fibrosis scores is unclear.</p><p><strong>Methods: </strong>A historical cohort comprising 6,949 non-cirrhotic Korean CHB patients without significant alanine aminotransferase elevation was investigated. The association of HBV DNA levels with the aspartate aminotransferase to platelet ratio index (APRI) and fibrosis (FIB)-4 score at baseline was analyzed using general linear models.</p><p><strong>Results: </strong>In HBeAg-negative patients (n=4,868), HBV DNA levels correlated linearly with both APRI and FIB-4 scores. In contrast, in HBeAg-positive patients (n=2,081), HBV DNA levels correlated inversely with both APRI and FIB-4 scores. Across the entire cohort, a significant non-linear parabolic relationship was identified between HBV DNA levels and fibrosis scores, independent of age and other covariates. Notably, moderate viral loads (6-7 log10 IU/mL) corresponded to the highest APRI and FIB-4 scores (p<0.001). Over a median 10-year follow-up, 435 patients (6.3%) developed HCC. Higher APRI scores ≥0.5 and FIB-4 scores ≥1.45 were significantly associated with elevated HCC risk (p<0.001 for both). HBV DNA level remained a significant predictive factor for HCC development, even after adjusting for APRI or FIB-4 scores.</p><p><strong>Conclusion: </strong>HBV viral load is significantly correlated with APRI and FIB-4 scores, and is also associated with HCC risk independent of those scores in CHB patients. These findings suggest that HBV DNA level is associated with hepatocarcinogenesis through both direct and indirect pathways.</p>","PeriodicalId":10275,"journal":{"name":"Clinical and Molecular Hepatology","volume":null,"pages":null},"PeriodicalIF":14.0,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11540400/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141723183","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Correspondence to editorial on "Macrophage ATG16L1 expression suppresses metabolic dysfunction-associated steatohepatitis progression by promoting lipophagy". 关于 "巨噬细胞 ATG16L1:治疗 NASH 的潜在候选者 "社论的通信。
IF 14 1区 医学 Q1 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2024-10-01 Epub Date: 2024-07-08 DOI: 10.3350/cmh.2024.0470
Qi Wang, Qingfa Bu, Haoming Zhou, Ling Lu
{"title":"Correspondence to editorial on \"Macrophage ATG16L1 expression suppresses metabolic dysfunction-associated steatohepatitis progression by promoting lipophagy\".","authors":"Qi Wang, Qingfa Bu, Haoming Zhou, Ling Lu","doi":"10.3350/cmh.2024.0470","DOIUrl":"10.3350/cmh.2024.0470","url":null,"abstract":"","PeriodicalId":10275,"journal":{"name":"Clinical and Molecular Hepatology","volume":null,"pages":null},"PeriodicalIF":14.0,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11540352/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141554246","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Correspondence to editorial on "Hepatocellular carcinoma prediction model performance decreases with long-term antiviral therapy in chronic hepatitis B patients". 回复"乙型肝炎抗病毒治疗期间 HCC 预测模型性能下降:还需注意什么?
IF 14 1区 医学 Q1 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2024-10-01 Epub Date: 2024-07-23 DOI: 10.3350/cmh.2024.0552
Xiaoqian Xu, Hong You, Jidong Jia, Yuanyuan Kong
{"title":"Correspondence to editorial on \"Hepatocellular carcinoma prediction model performance decreases with long-term antiviral therapy in chronic hepatitis B patients\".","authors":"Xiaoqian Xu, Hong You, Jidong Jia, Yuanyuan Kong","doi":"10.3350/cmh.2024.0552","DOIUrl":"10.3350/cmh.2024.0552","url":null,"abstract":"","PeriodicalId":10275,"journal":{"name":"Clinical and Molecular Hepatology","volume":null,"pages":null},"PeriodicalIF":14.0,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11540353/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141747512","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Unlocking the future: Machine learning sheds light on prognostication for early-stage hepatocellular carcinoma: Editorial on "Conventional and machine learning-based risk scores for patients with early-stage hepatocellular carcinoma". 开启未来:机器学习揭示早期肝细胞癌的预后。
IF 14 1区 医学 Q1 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2024-10-01 Epub Date: 2024-05-07 DOI: 10.3350/cmh.2024.0327
Junlong Dai, Jimmy Che-To Lai, Grace Lai-Hung Wong, Terry Cheuk-Fung Yip
{"title":"Unlocking the future: Machine learning sheds light on prognostication for early-stage hepatocellular carcinoma: Editorial on \"Conventional and machine learning-based risk scores for patients with early-stage hepatocellular carcinoma\".","authors":"Junlong Dai, Jimmy Che-To Lai, Grace Lai-Hung Wong, Terry Cheuk-Fung Yip","doi":"10.3350/cmh.2024.0327","DOIUrl":"10.3350/cmh.2024.0327","url":null,"abstract":"","PeriodicalId":10275,"journal":{"name":"Clinical and Molecular Hepatology","volume":null,"pages":null},"PeriodicalIF":14.0,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11540372/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140856540","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Unlocking the role of liver sinusoidal endothelial cells: Key players in liver fibrosis: Editorial on "Liver sinusoidal endothelial cell: An important yet often overlooked player in the liver fibrosis". 揭示肝窦状内皮细胞的作用:肝纤维化的关键角色。
IF 14 1区 医学 Q1 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2024-10-01 Epub Date: 2024-05-10 DOI: 10.3350/cmh.2024.0343
Yasuko Iwakiri
{"title":"Unlocking the role of liver sinusoidal endothelial cells: Key players in liver fibrosis: Editorial on \"Liver sinusoidal endothelial cell: An important yet often overlooked player in the liver fibrosis\".","authors":"Yasuko Iwakiri","doi":"10.3350/cmh.2024.0343","DOIUrl":"10.3350/cmh.2024.0343","url":null,"abstract":"","PeriodicalId":10275,"journal":{"name":"Clinical and Molecular Hepatology","volume":null,"pages":null},"PeriodicalIF":14.0,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11540341/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140897242","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Clinical and Molecular Hepatology
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1